Share on StockTwits

Research analysts at Barclays hoisted their target price on shares of Bioamber (NASDAQ:BIOA) from $10.70 to $13.00 in a report released on Monday, StockRatingsNetwork reports. The firm currently has an “overweight” rating on the stock. Barclays’ price target indicates a potential upside of 22.31% from the stock’s previous close.

Bioamber (NASDAQ:BIOA) traded up 3.49% on Monday, hitting $11.00. The stock had a trading volume of 15,870 shares. Bioamber has a 1-year low of $3.96 and a 1-year high of $11.59. The stock has a 50-day moving average of $7.98 and a 200-day moving average of $6.53. The company’s market cap is $202.7 million.

BioAmber Inc (NASDAQ:BIOA) is a chemical company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.